BioSpace News Archive

Business

Optinose Announces CEO Transition and Business Update

Optinose today announced that Peter Miller has stepped down as Chief Executive Officer and Board member, and that Ramy Mahmoud, MD, MPH has been appointed as Chief Executive Officer and Board member.

January 31, 2023
·
6 min read
Drug Development

First Wave BioPharma Announces Initiation of Phase 2 Trial Investigating Enhanced Adrulipase Formulation in Exocrine Pancreatic Insufficiency in Patients with Cystic Fibrosis

First Wave BioPharma, Inc. today announced that the Company will initiate its planned Phase 2 clinical trial of an enhanced enteric microgranule delivery formulation for adrulipase for the treatment of exocrine pancreatic insufficiency (EPI) in patients with cystic fibrosis (CF).

January 31, 2023
·
6 min read
Biotech Beach

Eyenuk Secures the First European Union MDR Certification for Autonomous AI Detection of Diabetic Retinopathy, Age-Related Macular Degeneration, and Glaucoma

Eyenuk has been approved to market its EyeArt® AI eye screening system in the European Union for the new uses of detecting age-related macular degeneration (AMD) and glaucomatous optic nerve damage (a sign of glaucoma).

January 31, 2023
·
5 min read
Drug Development

Tonix Pharmaceuticals Announces Presentation of Clinical and Non-Clinical TNX-1900 Data at the Annual Headache Cooperative of the Pacific (HCOP) Winter Conference

Tonix Pharmaceuticals Holding Corp. today announced that David C. Yeomans, Ph.D., presented data from clinical and nonclinical studies in an oral presentation at the 16th Annual Headache Cooperative of the Pacific (HCOP) Winter Conference on January 27, 2023.

January 31, 2023
·
7 min read
Business

uniQure and Apic Bio enter into global licensing agreement for APB-102, a clinical stage gene therapy for patients with ALS caused by mutations in SOD1

uniQure N.V. and Apic Bio today announced that they have entered into a global licensing agreement for APB-102 to treat superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS), a rare, genetic form of ALS.

January 31, 2023
·
7 min read
Business

Anavex Life Sciences to Announce Fiscal 2023 First Quarter Financial Results on Tuesday February 7, 2023Webcast and Conference Call To be Held Tuesday, February 7, 2023, 8:30 am ET

Anavex Life Sciences Corp. today announced that it will issue financial results for its quarter ended December 31, 2022 on Tuesday February 7, 2023.

January 31, 2023
·
3 min read
Business

Athira Pharma Announces Promotion of Kevin Church, Ph.D., to Chief Scientific Officer

Athira Pharma, Inc. today announced the promotion of Kevin Church, Ph.D., to Chief Scientific Officer.

January 31, 2023
·
4 min read
BioMidwest

CLS Americas and URN Announce Treatment of 20th & Final Patient in Clinical Study “Targeted MRI/ US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer”

CLS Americas announced the full twenty patients have been safely treated in the previously announced Phase I clinical study titled, “Targeted MRI/US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer.”

January 31, 2023
·
3 min read
Business

PolyPid to Report Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights on February 8, 2023

PolyPid Ltd. today announced that it will report its fourth quarter and full year 2022 financial results and operational highlights before the open of the U.S. stock markets on Wednesday, February 8, 2023.

January 31, 2023
·
1 min read
Business

BIO-TECHNE ANNOUNCES RETIREMENT, APPOINTMENT OF GENERAL COUNSEL

Bio-Techne Corporation (NASDAQ: TECH) today announced Shane Bohnen has been appointed Senior Vice President, General Counsel effective March 3 , 2023.

January 31, 2023
·
2 min read